Pharmaceutical Executive October 18, 2024
Mike Hollan

The company includes the technology in drug development, improving efficiency, and other areas.

Over the past few years, AI has become one of the most discussed technologies. The algorithm and machine-learning software makes it possible for data to be sorted, analyzed, and arranged on much fast timelines than previously thought possible. For the pharmaceutical industry, this has made the technology very valuable, due to the high amount of varied pieces of data that the industry relies upon.

Johnson & Johnson recently issued a press release detailing six of the ways that it incorporates AI into its various processes.

Jim Swanson, executive vice president and chief information officer at Johnson & Johnson, said in the press release, “In the next few...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Precision Medicine Hinges On Access To Genetic Counselors
RNA editing: emerging from CRISPR’s shadow
Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D
Dotmatics aims to speed drug development, break data silos with Geneious Luma
1st sickle cell gene therapy patient completes treatment

Share This Article